debate 10: what do we do after folfirinox? - jak is the new standard
Published 9 years ago • 583 plays • Length 11:34Download video MP4
Download video MP3
Similar videos
-
12:37
debate 10: what do we do after folfirinox? - gemcitabine is standard
-
12:08
pancreatic cancer debate: optimal therapy - adjuvant folfirinox
-
8:46
debate: optimal chemotherapy backbone for targeted agents in pancreatic cancer? - folfirinox
-
8:43
debate: optimal adjuvant therapy for resected pancreatic cancer? - gem/nab-paclitaxel or folfirinox
-
18:33
gemcitabine monotherapy vs. doublet therapy vs. folfirinox for metastatic pancreatic adenocarcinoma
-
7:54
pancreatic cancer debate: optimal therapy - preoperative chemo/chemoradiotherapy
-
4:08
chemotherapy (folfirinox) side effects
-
6:41
dr. tenover: the benefits of cepheid's xpert carba-r test
-
12:31
folfiri side effects
-
11:00
understanding the side effects of folfirinox
-
18:33
debate: how to treat borderline, resectable pancreatic cancer? - chemotherapy alone
-
10:42
brca pancreatic cancer maintenance debate: parp inhibitor or continued chemo? - parp inhibitor
-
17:38
deciding the initial chemotherapy for patients with metastatic pancreatic cancer
-
10:50
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - adjuvant therapy
-
8:27
debate 2: braf mutant mcrc patients - folfirinox/bev
-
5:08
gi chemotherapy education – overview: folfirinox
-
5:23
debate: optimal therapy for patients with resectable pancreatic cancer - neoadjuvant chemotherapy
-
10:48
debate: adjuvant treatment of pancreatic cancer - monotherapy
-
2:12
pancreatic survival improved with trial chemotherapy regimen after surgery
-
0:43
dr. wang-gillam on folfirinox combo for pancreatic adenocarcinoma
-
0:16
dr. weinberg discusses the use of folfirinox in older patients with metastatic pancreatic cancer